TREATMENT OF OVERATIVE BLADDER WITH A PERITRIGONAL INJECTION PARADIGM OF ONABOTULINUMTOXINA IS ASSOCIATED WITH A LOW INCIDENCE OF CLEAN INTERMITTENT CATHETERIZATION Meeting Abstract

publication date

  • August 1, 2019

webpage

published in

start page

  • S123

end page

  • S124

volume

  • 38